Level of glial cell derived neurotrophic factor in the blood plasma of rheumatoid arthritis patients and its relationship with alexithymia

dc.contributor.author	Shalkovskyi, Y.	en
dc.contributor.author	Stanislavchuk, M.	en
dc.date.accessioned	2025-03-05T15:36:53Z
dc.date.available	2025-03-05T15:36:53Z
dc.date.issued	2024
dc.identifier.citation	Shalkovskyi Y. Level of glial cell derived neurotrophic factor in the blood plasma of rheumatoid arthritis patients and its relationship with alexithymia / Y. Shalkovskyi, M. Stanislavchuk // Reumatologia. – 2024. – № 62 (2). – P. 94–100.	en
dc.identifier.other	DOI: https://doi.org/10.5114/reum/187110	en
dc.identifier.uri	https://dspace.vnmu.edu.ua/123456789/6946	en
dc.description.abstract	Abstract: Introduction: Glial cell derived neurotrophic factor (GDNF) has an important role in the pathogenetic mechanisms and clinical manifestations of rheumatoid arthritis (RA). Alexithymia is associated with a severe clinical course and worse prognosis, while the relationship between alexithymia and GDNF in RA patients has not been investigated before. The aims of the study were to investigate the GDNF level in blood plasma in RA patients depending on the presence of alexithymia and to evaluate the relationship of GDNF level with clinical manifestation and quality of life.	en
dc.language.iso	en	en
dc.publisher	Reumatologia	en
dc.subject	rheumatoid arthritis	en
dc.subject	glial cell derived neurotrophic factor	en
dc.subject	alexithymia	en
dc.title	Level of glial cell derived neurotrophic factor in the blood plasma of rheumatoid arthritis patients and its relationship with alexithymia	en
dc.type	Article	en